Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT07207239. We help you review the study, but cannot decide medical eligibility.
Enrolling By InvitationNCT07207239
Repetative Transcranial Magnetic Stimulation , theta-burst protocol for treatment-resistant depression
This study is enrolling by invitation in Hungary. It is testing repetative Transcranial Magnetic Stimulation , theta-burst protocol for treatment-resistant depression.
Depression, Transcranial Magnetic Stimulation, RepetitiveDeviceOver 18 Years
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Budapest, HungarySee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 13, 2025
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 54
- Sponsor
- Semmelweis University
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- Hungary
- Age range
- Over 18 Years
- Official registry ID
- NCT07207239
- Official title
- Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.
Recruitment & locations
By invitationBudapest
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Semmelweis University, a university.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Enrolling By InvitationNCT07161700
Safety study of SPT-300 (GlyphAllo) in depression
This study is enrolling by invitation in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.
RecruitingNCT07227454
Esketamine for depression
The registry lists this study as recruiting. Study locations are listed in the United States, in Brazil, in Hungary, ... Confirm recruitment at each site. It is testing esketamine for depression.
RecruitingNCT07065240
SPT-300 (GlyphAllo) for depression
The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Czechia, ... Confirm recruitment at each site. It is testing SPT-300 (GlyphAllo) for depression.